Ipratropium

Question 1

MOA

Answer 1

Relieves bronchospasm

blocking receptors in the smooth muscle of the bronchioles.

Question 2

Indications 4

Answer 2

relief of bronchospasm.
causes such as asthma, 
CORD, 
airway burns or 
smoke inhalation.

Question 3

Contraindications

Answer 3

known severe allergy

Question 4

Cautions

Answer 4

none

Question 5

Administration, Route, Dose

Answer 5

0.5 mg ampoule
Nebulised 8 l/m

ONE dose NOT repeated
> Administer 0.5 mg of ipratropium by nebuliser with the initial dose of salbutamol.

Question 6

MDI

Answer 6

mild or moderate.
(MDI) and spacer (commonly one puff, with six
breaths to empty the spacer after each puff, repeated six to twelve times), rather than
administering nebulised bronchodilators.